Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Generic omeprazole delayed-release capsules: in vitro performance evaluations.

Moore T, Smith A, Ye W, Toler DY, Westenberger BJ, Lionberger R, Raw A, Yu L, Buhse LF.

Drug Dev Ind Pharm. 2009 Aug;35(8):917-21. doi: 10.1080/03639040802698802.

PMID:
19555236
[PubMed - indexed for MEDLINE]
2.

Dissolution of omeprazole from delayed-release solid oral dosage forms.

Farinha A, Bica A, Martins JM, Pais JP.

Drug Dev Ind Pharm. 2000 Jul;26(7):785-90.

PMID:
10872100
[PubMed - indexed for MEDLINE]
3.

Dissolution testing for generic drugs: an FDA perspective.

Anand O, Yu LX, Conner DP, Davit BM.

AAPS J. 2011 Sep;13(3):328-35. doi: 10.1208/s12248-011-9272-y. Epub 2011 Apr 9.

PMID:
21479700
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Generic versus brand-name medicinal products: are they really interchangeable?

Motola D, De Ponti F.

Dig Liver Dis. 2006 Aug;38(8):560-2. Epub 2006 May 30. No abstract available.

PMID:
16731062
[PubMed - indexed for MEDLINE]
5.

Assessment of the pharmaceutical quality of omeprazole capsule brands marketed in Egypt.

El-Sayed A, Boraie NA, Ismail FA, El-Khordagui LK, Khalil SA.

East Mediterr Health J. 2007 Nov-Dec;13(6):1427-37.

PMID:
18341192
[PubMed - indexed for MEDLINE]
6.

Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.

Joti JJ, Nahar K, Hasan A, Azad MA, Ullah MA, Islam SM, Hasnat A.

Arzneimittelforschung. 2009;59(4):171-5. doi: 10.1055/s-0031-1296382.

PMID:
19517893
[PubMed - indexed for MEDLINE]
7.

Common deficiencies with bioequivalence submissions in abbreviated new drug applications assessed by FDA.

Liu Q, Davit BM, Cherstniakova SA, Dandamudi S, Walters JF, Lee CH, Raines KW, Ren K, Williamson LN, Conner DP.

AAPS J. 2012 Mar;14(1):19-22. doi: 10.1208/s12248-011-9312-7. Epub 2011 Dec 1.

PMID:
22130775
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Differences in the release of omeprazole in 4 commercial preparations: influence of pH and ionic concentration].

Navarro MA, Raei N, Torres F, Granero L, García-Zaragoza E, Esplugues JV, Esteban Peris J.

Gastroenterol Hepatol. 1998 Feb;21(2):63-70. Spanish.

PMID:
9549180
[PubMed - indexed for MEDLINE]
9.

Classification of torasemide based on the Biopharmaceutics Classification System and evaluation of the FDA biowaiver provision for generic products of CLASS I drugs.

Khan MZ, Rausl D, Radosević S, Filić D, Danilovski A, Dumić M, Knezević Z.

J Pharm Pharmacol. 2006 Nov;58(11):1475-82.

PMID:
17132210
[PubMed - indexed for MEDLINE]
10.

Omeprazole/Antacid-powder suspension-Santarus: omeprazole/sodium bicarbonate powder-Santarus, SAN 05.

[No authors listed]

Drugs R D. 2004;5(6):349-50. Review.

PMID:
15563239
[PubMed - indexed for MEDLINE]
11.
12.

Comparison in vitro felodipine release rate from the original versus generic product with controlled release of the drug.

Vetchy D, Vetcha M, Rabiskova M, Gryczova E, Bartosikova L.

Medicina (Kaunas). 2007;43(4):326-31.

PMID:
17485960
[PubMed - indexed for MEDLINE]
Free Article
13.

Analysis of bead sizes for MR capsules labeled for sprinkle.

Nagavelli LR, Lionberger RA, Sayeed VA, Yu L, Allgire J, Smith A, Wokovich A, Westenberger BJ, Buhse L.

AAPS PharmSciTech. 2010 Dec;11(4):1508-10. doi: 10.1208/s12249-010-9529-2. Epub 2010 Oct 9.

PMID:
20936439
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Pharmacokinetics of budesonide controlled-release capsules when taken with omeprazole.

Edsbäcker S, Larsson P, Bergstrand M.

Aliment Pharmacol Ther. 2003 Feb;17(3):403-8.

PMID:
12562453
[PubMed - indexed for MEDLINE]
Free Article
15.

Omeprazole--a new formulation.

Armstrong D.

Can J Gastroenterol. 1997 Nov-Dec;11(8):655-6. No abstract available.

PMID:
9459043
[PubMed - indexed for MEDLINE]
16.

Pharmacokinetic comparison of omeprazole capsules and a simplified omeprazole suspension.

Song JC, Quercia RA, Fan C, Tsikouris J, White CM.

Am J Health Syst Pharm. 2001 Apr 15;58(8):689-94.

PMID:
11329761
[PubMed - indexed for MEDLINE]
18.

Acid-suppressive effects of generic omeprazole: comparison of three brands of generic omeprazole with original omeprazole.

Shimatani T, Inoue M, Kuroiwa T, Xu J, Mieno H, Tazuma S.

Dig Liver Dis. 2006 Aug;38(8):554-9. Epub 2006 Mar 9.

PMID:
16524789
[PubMed - indexed for MEDLINE]
19.

Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.

Strauch S, Jantratid E, Dressman JB.

J Pharm Pharmacol. 2009 Mar;61(3):331-7. doi: 10.1211/jpp/61.03.0007.

PMID:
19222905
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk